Recent ihps items

Diversity in U.S. Medical Schools: Revitalizing Efforts to Increase Diversity in a Changing Context, 1960s-2000s

Tue, 9 Mar 2010 00:00:00 +0000

Diversity in U.S. Medical Schools: Revitalizing Efforts to Increase Diversity in a Changing Context, 1960s-2000s

Does Centralized Intake Improve Drug Abuse Treatment Outcomes?

Thu, 9 Mar 2006 00:00:00 +0000

This study was designed to assess whether centralized intake and assessment in a drug abuse treatment system would lead to improved outcomes. Clients entering treatment through a centralized intake unit (CIU) or through individual programs (non-CIU) were interviewed at admission, and at I month and I year postadmission. Interviews included measures of treatment access and satisfaction, psychiatric symptoms, social support, and Addiction Severity Index composite scores. At treatment entry, CIU participants had more employment and psychological problems and lower social support, were more often required to be in treatment, and were more often placed on a waiting list. In analyses controlling for baseline differences between groups, there were main effects of time, but no CIU status effects or CIU status by time interactions. The CIU may have improved access to treatment for a more disabled population; however, clients entering treatment through the CIU did not have better outcomes...

Tobacco Interests or the Public Interests: Twenty-years of Tobacco Industry Strategies to Undermine Airline Smoking Restrictions

Wed, 22 Feb 2006 00:00:00 +0000

Tobacco Interests or the Public Interests: Twenty-years of Tobacco Industry Strategies to Undermine Airline Smoking Restrictions

Multi-Level Assessment Protocol (MAP) for Adoption in Multisite Clinical Trials

Mon, 9 Jan 2006 00:00:00 +0000

The National Institute on Drug Abuse (NIDA) Clinical Trials Network (CTN) is intended to test promising drug abuse treatment models in multisite clinical trials and to support adoption of new interventions into clinical practice. Using qualitative research methods we asked the following question: how might the technology of multisite clinical trials be modified to better support adoption of tested interventions? A total of 42 participants, representing eight organizational levels ranging from clinic staff to clinical trial leaders, were interviewed about their role in the clinical trial, its interactions with clinics, and intervention adoption. Among eight clinics participating in the clinical trial, we found adoption of the tested intervention in one clinic only. Analysis of interview data revealed four conceptual themes likely to affect adoption and may be informative in future multisite clinical trials. Planning for adoption in the early stages of protocol development will...

Evaluation of Probation Case Management (PCM) for Drug-Involved Women Offenders

Tue, 8 Nov 2005 00:00:00 +0000

Based on availability of case management services, drug-involved women offenders entered either a probation case management (PCM) intervention (n = 65) or standard probation (n = 44). Participants were placed in the case management condition until all slots were filled, then placed in standard probation until case management slots opened. Participants were interviewed at program entry and at 6- and 12-month follow-up using measures of substance abuse, psychiatric symptoms, and social support. Results showed modest change over time in both conditions, but PCM did not result in more services or treatment, or better outcomes than standard probation. These findings are discussed in the context of study limitations and in the context of state initiatives like those in Arizona and California designed to apply treatment as an alternative to incarceration.

Science in Regulatory Policy Making: Case Studies in the Development of Workplace Smoking Restrictions